Oral [60]fullerene reduces neuroinflammation to alleviate Parkinson's disease via regulating gut microbiome

Neuroinflammation is considered to drive the pathogenic process of neuronal degeneration in Parkinson's disease (PD). However, effective anti-neuroinflammation therapeutics for PD still remain dissatisfactory. Here we explore a robust therapeutic strategy for PD using anti-neuroinflammatory ful...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xue, Deng, Ruijun, Li, Jie, Li, Hui, Xu, Zhe, Zhang, Lei, Feng, Linyin, Shu, Chunying, Zhen, Mingming, Wang, Chunru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526674/
https://www.ncbi.nlm.nih.gov/pubmed/37771782
http://dx.doi.org/10.7150/thno.85711

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526674/
https://www.ncbi.nlm.nih.gov/pubmed/37771782
http://dx.doi.org/10.7150/thno.85711

Ejemplares similares